We are live on ! Find out more
EXAS

Exact Sciences
EXAS

Delisted

EXAS was delisted on the 20th of March, 2026.

Back to rankings

151 hedge funds and large institutions have $916M invested in Exact Sciences in 2014 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 51 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 12

64% more call options, than puts

Call options by funds: $67.8M | Put options by funds: $41.3M

22% more capital invested

Capital invested by funds: $752M → $916M (+$164M)

15% more funds holding

Funds holding: 131 → 151 (+20)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 51

Holders
151
Holders Change
+20
Holders Change %
+15.27%
% of All Funds
4.36%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
32
Increased
49
Reduced
51
Closed
12
Calls
$67.8M
Puts
$41.3M
Net Calls
+$26.5M
Net Calls Change
+$31.6M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$26.7M
2
Fidelity International
Fidelity International
Bermuda
+$9.85M
3
GGHC
Gilder Gagnon Howe & Co
New York
+$9.31M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$9.01M
5
SI
Stephens Inc
Arkansas
+$4.59M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$41.8M
2
WA
Wasatch Advisors
Utah
-$12.1M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.51M
4
PC
Pier Capital
Connecticut
-$6.71M
5
MHP
Manatuck Hill Partners
Connecticut
-$2.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
76
ProShare Advisors
Maryland
$1.01M +$963K +71,293 New
1CM
77
1492 Capital Management
Wisconsin
$947K +$903K +66,851 New
RhumbLine Advisers
78
RhumbLine Advisers
Massachusetts
$930K -$35.4K -2,620 -4%
LCG
79
Lisanti Capital Growth
New York
$910K +$867K +64,215 New
JG
80
Jefferies Group
New York
$904K +$376K +27,869 +78%
BA
81
BlackRock Advisors
Delaware
$879K +$211K +15,627 +34%
CCM
82
Coe Capital Management
Illinois
$822K -$1.63M -120,844 -68%
American Century Companies
83
American Century Companies
Missouri
$799K -$55.8K -4,130 -7%
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
$790K -$41.4K -3,067 -5%
Deutsche Bank
85
Deutsche Bank
Germany
$781K +$289K +21,390 +63%
NFA
86
Nationwide Fund Advisors
Ohio
$770K -$2.23K -165 -0.3%
SM
87
Sabby Management
Florida
$765K +$193K +14,271 +36%
FAM
88
Fortaleza Asset Management
Illinois
$739K -$81.5K -6,035 -10%
CCM
89
Cadence Capital Management
Massachusetts
$706K +$673K +49,820 New
Barclays
90
Barclays
United Kingdom
$694K +$163K +12,081 +32%
AIG
91
American International Group
New York
$679K +$15.5K +1,150 +2%
VOYA Investment Management
92
VOYA Investment Management
Georgia
$672K – – –
Ameriprise
93
Ameriprise
Minnesota
$539K -$383K -28,324 -43%
Citadel Advisors
94
Citadel Advisors
Florida
$538K +$75.1K +5,560 +17%
ARC
95
Absolute Return Capital
Massachusetts
$454K +$433K +32,056 New
BCM
96
Basso Capital Management
Connecticut
$425K +$405K +30,000 New
EC
97
EJF Capital
Virginia
$425K +$405K +30,000 New
KeyBank National Association
98
KeyBank National Association
Ohio
$421K -$87.6K -6,490 -18%
T. Rowe Price Associates
99
T. Rowe Price Associates
Maryland
$400K -$116K -8,600 -23%
CC
100
Curian Capital
Colorado
$398K +$380K +28,105 New
2 3
4
5 6

EXAS Hedge Fund Activity: Q1 2014 in Review

151 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2014, worth a combined $916M — up 22% from $752M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new EXAS positions and 12 closed out — a net gain of 20 holders — while 49 added to existing stakes and 51 trimmed.

The largest buyer was Invesco, adding an estimated $26.7M. The largest seller was OrbiMed, cutting an estimated $41.8M.

  • 151 institutional investors held Exact Sciences (EXAS) as of Q1 2014, up from 131 in Q4 2013.
  • Funds reported $916M of Exact Sciences stock for Q1 2014, up 22% quarter-over-quarter.
  • 32 funds opened new Exact Sciences positions in Q1 2014 and 12 closed out, a net change of +20 holders.
  • The largest Exact Sciences buyer in Q1 2014 was Invesco, an estimated $26.7M added.
  • The largest Exact Sciences seller in Q1 2014 was OrbiMed, an estimated $41.8M sold.

Based on aggregated 13F filings for Q1 2014.